EGFR and COVID-19: The results show that Diosmetin can highly bind with novel coronavirus-specific proteins and core gene proteins, suggesting that the effect of Diosmetin on BRCA/COVID-19 may be targeted by EGFR, AKT1, and GSK3B proteins.